Cancer research study shows how novel drug screen can individualize cancer therapy

US increasingly unlikely to meet Biden’s July 4 vax goal
8 June 2021
People more afraid of catching COVID-19 are more judgemental, study finds
9 June 2021

Cancer research study shows how novel drug screen can individualize cancer therapy

A study conducted by researchers at the Ludwig Center at Harvard has demonstrated how a drug screening method known as dynamic BH3 profiling can be used to quickly identify potentially effective combinations of existing drugs for personalized cancer therapy.

Comments are closed.